Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0X8NN
|
|||
Drug Name |
PMID28766366-Compound-Scheme11
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) UNIVERSITE DE REIMS CHAMPAGNE-ARDENNE UNIVERSITE PARIS DIDEROT PARIS 7
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H14N2O3
|
|||
Canonical SMILES |
C1=CC(=CC=C1C2=CNC3=C2C=C(C=N3)C4=CC(=C(C=C4)O)O)O
|
|||
InChI |
1S/C19H14N2O3/c22-14-4-1-11(2-5-14)16-10-21-19-15(16)7-13(9-20-19)12-3-6-17(23)18(24)8-12/h1-10,22-24H,(H,20,21)
|
|||
InChIKey |
HBCKPNCVCXUSEU-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target Info | Inhibitor | [1] |
Target's Patent Info | Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.Expert Opin Ther Pat. 2017 Nov;27(11):1183-1199. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.